GW Pharma (GWPH) Announces Positive Top-Line Data from Epidiolex Phase 3 - StreetInsider.com

New Cannabis Ventures

GW Pharma (GWPH) Announces Positive Top-Line Data from Epidiolex Phase 3 StreetInsider.com News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. GW Pharmaceuticals plc (Nasdaq: GWPH) announces positive results of the first randomized, double-blind, placebo-controlled ... UPDATE 1-GW Pharma says cannabis-based epilepsy drug meets main goalReuters GW Pharma Marijuana Drug Confirms Seizure Benefit in Second Pivotal TrialTheStreet.com Epidiolex to be trialled in West SyndromeEpilepsy Research UK DIGITALLOOK -London South East (registration) (blog) all 9 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNGsCCTdUeyWrlqvngJMMAq-3AYZPg&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779141848884&ei=HSBxV9CLK4GQ3AGmoIWgBg&url=http://www.streetinsider.com/Corporate%2BNews/GW%2BPharma%2B(GWPH)%2BAnnounces%2BPositive%2BTop-Line%2BData%2Bfrom%2BEpidiolex%2BPhase%2B3/11774535.html
via IFTTT